EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of COVID‐19 on Incident Diabetes in Pediatric Patients: Findings From the National COVID‐19 Cohort Collaborative (N3C)

Rachel Wong iD, Talia Wiggen iD, Margaret A Hall iD, Steven G Johnson iD, Jared D Huling iD, Lindsey E Turner iD, Kenneth J Wilkins iD, Hsin-Chieh Yeh iD, Til Stürmer iD, Carolyn T Bramante iD, Zachary Butzin-Dozier iD, John B Buse iD und 2 weitere

Pediatric Diabetes · 2025

DOI: 10.1155/pedi/3545727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Diabetes, 2025. Verfasst von Rachel Wong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA, stonybrook.edu. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Studies showing increased diabetes incidence in pediatric patients after COVID‐19 are from data early in the pandemic, and some studies found conflicting results. Our objective was to evaluate trends in pediatric diabetes incidence and whether COVID‐19 was associated with increased risk across viral variant periods. Research Design and Methods We conducted a retrospective cohort study using National COVID‐19 Cohort Collaborative data to evaluate incident diabetes risk among COVID‐19‐positive pediatric patients compared to COVID‐19‐negative patients or controls with acute respiratory illness. Cohorts were weighted on demographics, data site, and body mass index percentile. The primary outcome was the cumulative incidence ratio (CIR) of incident diabetes for each viral variant era.

Results

There was no difference in the risk of incident diabetes in pediatric patients after COVID‐19 compared to patients in COVID‐19 negative or ARI control groups during any of the viral variant periods (e.g., ancestral period CIR 1.03, 95% CI 0.65–1.41). The predominant subtype of incident diabetes was T2D. Incidence rates over time followed a U‐shaped curve, with the highest incidence in the ancestral variant period.

Conclusions

COVID‐19 was not associated with an increased risk of diabetes in pediatric patients. Incidence rates were highest early in the pandemic, and mirrored patterns of pandemic‐era healthcare utilization. The predominance of incident T2D subtype is concerning for the adverse effects of pandemic‐related lifestyle changes among pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes MellitusHumansChildMaleFemaleIncidenceRetrospective StudiesAdolescentChild, PreschoolSARS-CoV-2United StatesCohort StudiesInfant

Autor:innen und Institutionen

  • Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA, stonybrook.edu.
  • Department of Internal Medicine, Stony Brook University, Stony Brook, New York, USA, stonybrook.edu.
  • Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA, umn.edu.
  • Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA, emory.edu.
  • Institute for Health Informatics, University of Minnesota, Minneapolis, Minnesota, USA, umn.edu.
  • Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA, umn.edu.

ORCID-Profile: Rachel Wong, Talia Wiggen, Margaret A Hall, Steven G Johnson, Jared D Huling, Lindsey E Turner, Kenneth J Wilkins, Hsin-Chieh Yeh, Til Stürmer, Carolyn T Bramante, Zachary Butzin-Dozier, John B Buse, Jane Reusch

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NICHD NIH HHS
  • CLC NIH HHS
  • NIDA NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Wong, R., Wiggen, T., Hall, M. A., Johnson, S. G., Huling, J. D., Turner, L. E., Wilkins, K. J., Yeh, H. C., Stürmer, T., Bramante, C. T., Butzin-Dozier, Z., Buse, J. B., Reusch, J., & N3C Consortium (2025). The Effect of COVID‐19 on Incident Diabetes in Pediatric Patients: Findings From the National COVID‐19 Cohort Collaborative (N3C). Pediatric Diabetes. https://doi.org/10.1155/pedi/3545727

Vancouver

Wong R, Wiggen T, Hall MA, Johnson SG, Huling JD, Turner LE, et al. The Effect of COVID‐19 on Incident Diabetes in Pediatric Patients: Findings From the National COVID‐19 Cohort Collaborative (N3C). Pediatric Diabetes. 2025. doi:10.1155/pedi/3545727

BibTeX
@article{Wong2025,
  author = {Wong, Rachel and Wiggen, Talia and Hall, Margaret A and Johnson, Steven G and Huling, Jared D and Turner, Lindsey E and Wilkins, Kenneth J and Yeh, Hsin-Chieh and Stürmer, Til and Bramante, Carolyn T and Butzin-Dozier, Zachary and Buse, John B and Reusch, Jane and N3C Consortium, N3C Consortium},
  title = {The Effect of COVID‐19 on Incident Diabetes in Pediatric Patients: Findings From the National COVID‐19 Cohort Collaborative (N3C)},
  journal = {Pediatric Diabetes},
  year = {2025},
  doi = {10.1155/pedi/3545727}
}
Kostenlos starten →